(Total Views: 365)
Posted On: 06/26/2025 5:10:12 AM
Post# of 154570
Quote:
It will not be to difficult to show our prove , we need 700 mg . Just to present carefully results of our 28 patients with TNBC should be enough. It is really very disappointing for patients and us to deal with 350 mg during every oncology trial knowing it is not working for our patients .
Agree completely. We should not have to handicap our own trials with a suboptimal dose.
How can we as shareholders present this case to management. Maybe a letter signed by a bunch of us to Dr. Jay?
It would be even more optimal if we could let the FDA know they are handicapping us, but I have no idea how we can take action to inform the FDA, nor do I know if this is a good idea. Look how stupidly, petulantly, and wrongfully Janet Woodcok responded the last time there was shareholder pressure.
(5)
(0)
